Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Total Non-Current Liabilities (2009 - 2026)

Updated

Abeona Therapeutics (ABEO) posted Total Non-Current Liabilities of $31.85 million for Q3 2026, down 14.6% from $37.3 million a year earlier but up 3.6% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Abeona Therapeutics' Total Non-Current Liabilities came in at $41.45 million, up 26.0% from FY2024.

  • Annual Total Non-Current Liabilities has increased for three consecutive years, with a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
  • In prior years, Abeona Therapeutics' Total Non-Current Liabilities was $32.89 million in FY2024 (+84.5%), $17.82 million in FY2023 (+0.2%), $17.8 million in FY2022 (-36.9%) and $28.21 million in FY2021 (+64.7%).
  • Quarterly Total Non-Current Liabilities has run from a low of $16.93 million in Q3 2023 to a high of $52.5 million in Q2 2025 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities increased in five of the last eight quarters, with growth averaging 20.1%.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q2 2022, with growth of 117.9%; the weakest was Q1 2023, with a decline of 42.4%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $30.74 million (Q2 2026), $40.04 million (Q1 2026) and $41.45 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 102.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 117.60 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -36.84 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 36.05 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 96.04 Bn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn 31.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 31.85 Mn
Jun 30, 2026 30.74 Mn
Mar 31, 2026 40.04 Mn
Dec 31, 2025 41.45 Mn
Sep 30, 2025 37.30 Mn
Jun 30, 2025 52.50 Mn
Mar 31, 2025 33.20 Mn
Dec 31, 2024 32.89 Mn
Sep 30, 2024 31.11 Mn
Jun 30, 2024 31.19 Mn
Mar 31, 2024 34.01 Mn
Dec 31, 2023 17.82 Mn
Sep 30, 2023 16.93 Mn
Jun 30, 2023 18.18 Mn
Mar 31, 2023 17.21 Mn
Dec 31, 2022 17.80 Mn
Sep 30, 2022 22.10 Mn
Jun 30, 2022 26.48 Mn
Mar 31, 2022 29.87 Mn
Dec 31, 2021 28.21 Mn
API Access

Abeona Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ABEO&period=max&api_key=YOUR_API_KEY